Microneedling for Hair Loss: Does It Actually Work?

If you’ve spent any time in hair-loss communities, microneedling (usually with a 1.5 mm dermaroller) is the most-recommended adjunct treatment after minoxidil and finasteride. The story goes: roll the scalp, the controlled micro-injuries trigger wound-healing signalling, follicles wake up, and topical drugs absorb better. Studies show meaningfully larger hair counts when you add microneedling to minoxidil than minoxidil alone.

Most of that is correct. Some of it is overstated. Here’s what the evidence actually shows.

What microneedling actually is

A microneedling device is a roller, stamp, or motorised pen with very fine needles, typically 0.25 mm to 2.0 mm in length, that create thousands of tiny, controlled puncture wounds in the skin. The technique started in dermatology as a treatment for scarring and skin texture, and was adapted for the scalp once researchers noticed wound-healing signals appeared to influence hair follicles.

The two formats most people encounter:

• Home dermaroller. Manual roller with a head of fixed-length needles. Cheap ($15–50), simple to use, but inconsistent depth and pressure. Hygiene is on you; non-sterile rollers are a real infection risk.
• In-office microneedling. Typically a motorised pen device (e.g., the Dermapen, SkinPen) used by a clinician at controlled depth. More precise, sterile, but expensive ($200–500 per session).

The needle depth matters more than the device. Most published trials for hair loss use 1.5 mm as the working depth.

How it’s supposed to work

Three mechanisms have been proposed in the literature³ :

1. Wound-healing cascade. Micro-injuries trigger release of growth factors (PDGF, VEGF, TGF-β) and cytokines that, in animal and cell-culture studies, increase hair-follicle proliferation and prolong the anagen (growth) phase.

2. Wnt/β-catenin signalling. Wound healing activates Wnt-pathway signalling in the dermal papilla cells at the base of hair follicles. Wnt is one of the dominant control pathways for the hair cycle; activating it in miniaturising follicles may push them back into productive growth⁴ .

3. Enhanced topical absorption. Microscopic channels in the stratum corneum increase the penetration of topically-applied drugs, particularly minoxidil. In vitro models suggest 3–4× greater minoxidil delivery to the dermis after microneedling versus untreated skin.

The first two mechanisms suggest standalone effect. The third explains why microneedling + minoxidil performs so much better than either alone, and that synergy is where the strongest evidence sits.

What the trials show

Microneedling + minoxidil (the strong evidence)

The pivotal trial is Dhurat et al. 2013, a randomised evaluator-blinded comparison of weekly microneedling (1.5 mm) plus topical minoxidil 5% versus minoxidil alone in 100 men with androgenetic alopecia¹ :

• At week 12: the microneedling + minoxidil group showed an average increase of ~91 hairs/cm² compared with ~22 hairs/cm² for minoxidil alone, roughly a 4× greater hair count gain.
• By week 12, 82% of microneedling-group patients reported >50% improvement by self-assessment, versus 4.5% in the minoxidil-only group.
• 8 of the 12 patients in the microneedling group who had been long-term minoxidil non-responders showed a positive response after adding microneedling.

Subsequent trials have largely replicated the direction of this effect, though the magnitude varies. Faghihi et al. 2021 showed comparable hair-count gains with combination therapy versus minoxidil alone over 6 months² , and Bao et al. 2020 found 1.5 mm needle depth outperformed 0.5 mm for AGA outcomes⁵ .

The honest summary: microneedling combined with minoxidil clearly outperforms minoxidil alone in randomised trials, with most of the additional gain visible by 12–24 weeks.

Standalone microneedling

The evidence base for microneedling without concurrent topical drug therapy is thinner. Several small open-label studies show modest hair density improvements over 6–12 months with standalone microneedling, but the effect size is smaller than the combination data and the studies are typically uncontrolled. There is no large randomised trial of standalone microneedling that holds up to the same standard as the combination data.

Practical implication: if you’re going to microneedle for AGA, you should be on topical minoxidil too. The synergy is what makes it worth doing.

Microneedling vs. PRP

Some clinics offer microneedling combined with platelet-rich plasma (PRP), using the micro-channels created by needling to deliver platelet-derived growth factors directly to the follicle. The evidence here is small and inconsistent, with some trials showing additive benefit and others showing no advantage over PRP alone. We cover PRP separately in our PRP for hair loss guide.

Format comparison

Practical protocol (if you’re going to do it at home)

The literature consistently supports a few specifics:

• Needle depth: 1.5 mm. Shorter (0.5 mm, 1.0 mm) rollers showed smaller effects in head-to-head trials. Longer (>2.0 mm) doesn’t increase benefit and increases scarring risk.
• Frequency: weekly. Some protocols use bi-weekly. More-frequent use (e.g., daily) doesn’t increase benefit and likely impairs healing between sessions.
• Apply minoxidil 30+ minutes after rolling, not immediately before or during. Applying minoxidil to freshly micro-injured skin increases systemic absorption substantially, and the delivery boost from microneedling persists for hours after the procedure, so a delay doesn’t sacrifice benefit.
• Rotate the rolling direction. Roll the same area in horizontal, vertical, and both diagonal directions for even coverage.
• Sterilise the roller before and after every use with 70% isopropyl alcohol for at least 5 minutes. Replace the roller every 6–10 uses; needles dull quickly.
• Stop immediately if you see signs of infection: increased redness 24+ hours later, warmth, pus, fever. Topical antibiotics and a clinician visit; don’t tough it out.

Plan for at least 6 months before judging whether it’s working. Earliest visible effects appear at 12–24 weeks; full effect compounds over 6–12 months alongside minoxidil’s own timeline.

Side effects and risks

Microneedling is generally well tolerated, but the real risks are worth naming:

• Transient irritation, redness, mild bleeding. Expected immediately after rolling, resolves in hours.
• Post-procedure shedding. Some patients see a brief increase in hair fall in the first 4–6 weeks (similar to the “dread shed” with minoxidil: synchronisation of the hair cycle, not failure).
• Infection. Rare but real. The risk is highest with non-sterile rollers and applying topical drugs immediately after rolling. Most cases are bacterial (folliculitis); rare cases of mycobacterial or viral transmission have been reported.
• Scarring. Exceedingly rare with appropriate depth (≤1.5 mm) and proper technique. Higher with deeper needles, excessive force, or repeated rolling over the same area in one session.
• Hyperpigmentation. More common in darker skin types; usually resolves over months.
• Accelerated systemic absorption of minoxidil. Meaningful enough to occasionally cause systemic minoxidil side effects (dizziness, swelling, palpitations) in people who didn’t have them before. The 30-minute delay between rolling and minoxidil application reduces but doesn’t eliminate this.

When NOT to microneedle

This is the most important section to read before starting:

• Active scarring alopecia (FFA, LPP, CCCA, dissecting cellulitis). Microneedling can accelerate the inflammatory process and make outcomes worse. If you have any redness, scaling, itching, or pain on the scalp, get a dermatologist’s diagnosis before microneedling.
• Active alopecia areata. Physical trauma can trigger or worsen AA in genetically susceptible individuals (the Koebner phenomenon). Don’t use microneedling if you have AA.
• Active scalp infection. Folliculitis, fungal infections, herpes simplex outbreaks. Treat the infection first.
• Bleeding disorders or anticoagulants. Discuss with your prescribing doctor first.
• Recent isotretinoin (Accutane) use within the last 6 months. Increased scarring risk.
• Keloid-prone skin. Increased risk of abnormal scarring.

When to see a dermatologist

• Anything other than classic, gradually-progressing androgenetic alopecia. See our types of hair loss guide and diagnostic guide, since microneedling can hurt rather than help in many non-AGA conditions.
• If you’ve been microneedling consistently for 6+ months alongside minoxidil with no visible improvement.
• If you experience signs of infection, persistent redness, or unusual scarring after rolling.
• If you’re considering combining microneedling with PRP, oral medications, or other in-office procedures, where coordination matters.

What this article doesn’t cover

We’ve focused on microneedling for androgenetic alopecia in adults. We’ve left out detailed coverage of microneedling for alopecia areata (mostly contraindicated), scarring alopecias (contraindicated), and paediatric use (not enough evidence). PRP is covered separately in its own guide. The combination of microneedling with low-level laser therapy or other devices is also out of scope here.

If you’re considering microneedling and you’re not sure your diagnosis is AGA, talk to a dermatologist before starting. Getting the diagnosis right is the difference between a useful adjunct treatment and one that worsens an underlying condition. Anything in this article is general education, not personal medical advice.